268 related articles for article (PubMed ID: 12970087)
1. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat.
Mulcahy NJ; Ross J; Rothwell NJ; Loddick SA
Br J Pharmacol; 2003 Oct; 140(3):471-6. PubMed ID: 12970087
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat.
Loddick SA; Rothwell NJ
J Cereb Blood Flow Metab; 1996 Sep; 16(5):932-40. PubMed ID: 8784237
[TBL] [Abstract][Full Text] [Related]
3. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat.
Stroemer RP; Rothwell NJ
J Cereb Blood Flow Metab; 1997 Jun; 17(6):597-604. PubMed ID: 9236716
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist.
Yang GY; Liu XH; Kadoya C; Zhao YJ; Mao Y; Davidson BL; Betz AL
J Cereb Blood Flow Metab; 1998 Aug; 18(8):840-7. PubMed ID: 9701345
[TBL] [Abstract][Full Text] [Related]
5. Endogenous interleukin-1 receptor antagonist is neuroprotective.
Loddick SA; Wong ML; Bongiorno PB; Gold PW; Licinio J; Rothwell NJ
Biochem Biophys Res Commun; 1997 May; 234(1):211-5. PubMed ID: 9168991
[TBL] [Abstract][Full Text] [Related]
6. Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat.
Relton JK; Martin D; Thompson RC; Russell DA
Exp Neurol; 1996 Apr; 138(2):206-13. PubMed ID: 8620919
[TBL] [Abstract][Full Text] [Related]
7. Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection.
Greenhalgh AD; Galea J; Dénes A; Tyrrell PJ; Rothwell NJ
Br J Pharmacol; 2010 May; 160(1):153-9. PubMed ID: 20412072
[TBL] [Abstract][Full Text] [Related]
8. Causal links between brain cytokines and experimental febrile convulsions in the rat.
Heida JG; Pittman QJ
Epilepsia; 2005 Dec; 46(12):1906-13. PubMed ID: 16393156
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
[TBL] [Abstract][Full Text] [Related]
10. New evidence of neuroprotection by lactate after transient focal cerebral ischaemia: extended benefit after intracerebroventricular injection and efficacy of intravenous administration.
Berthet C; Castillo X; Magistretti PJ; Hirt L
Cerebrovasc Dis; 2012; 34(5-6):329-35. PubMed ID: 23154656
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain.
Betz AL; Yang GY; Davidson BL
J Cereb Blood Flow Metab; 1995 Jul; 15(4):547-51. PubMed ID: 7790404
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats.
Wang X; Barone FC; Aiyar NV; Feuerstein GZ
Stroke; 1997 Jan; 28(1):155-61; discussion 161-2. PubMed ID: 8996505
[TBL] [Abstract][Full Text] [Related]
13. Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat.
Zuhayra M; Zhao Y; von Forstner C; Henze E; Gohlke P; Culman J; Lützen U
Neuropathol Appl Neurobiol; 2011 Dec; 37(7):738-52. PubMed ID: 21366664
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia.
Patzer A; Zhao Y; Stöck I; Gohlke P; Herdegen T; Culman J
Eur J Neurosci; 2008 Nov; 28(9):1786-94. PubMed ID: 18973594
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective activity of a nanoparticulate formulation of the glycineB site antagonist MRZ 2/576 in transient focal ischaemia in rats.
Sopala M; Schweizer S; Schäfer N; Nürnberg E; Kreuter J; Seiller E; Danysz W
Arzneimittelforschung; 2002; 52(3):168-74. PubMed ID: 11963643
[TBL] [Abstract][Full Text] [Related]
16. Activation of nuclear factor-kappaB signaling pathway by interleukin-1 after hypoxia/ischemia in neonatal rat hippocampus and cortex.
Hu X; Nesic-Taylor O; Qiu J; Rea HC; Fabian R; Rassin DK; Perez-Polo JR
J Neurochem; 2005 Apr; 93(1):26-37. PubMed ID: 15773902
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury.
Sanderson KL; Raghupathi R; Saatman KE; Martin D; Miller G; McIntosh TK
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1118-25. PubMed ID: 10532636
[TBL] [Abstract][Full Text] [Related]
18. Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window.
Nurmi A; Vartiainen N; Pihlaja R; Goldsteins G; Yrjänheikki J; Koistinaho J
J Neurochem; 2004 Nov; 91(3):755-65. PubMed ID: 15485504
[TBL] [Abstract][Full Text] [Related]
19. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK
J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats.
Hagberg H; Gilland E; Bona E; Hanson LA; Hahin-Zoric M; Blennow M; Holst M; McRae A; Söder O
Pediatr Res; 1996 Oct; 40(4):603-9. PubMed ID: 8888290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
